RTTNews | Jun 17, 2021 10:19AM EDT

10:18 Thursday, June 17, 2021 (RTTNews.com) - Shares of biopharmaceutical company Clearside Biomedical, Inc. (CLSD) are trading up 28 percent on Thursday. The stock has been on an upward trajectory ever since it announced positive safety results from an early-stage trial for the treatment of a chronic eye disorder earlier this week.

On Tuesday, the company announced positive safety results from Cohort 1 of OASIS, its ongoing Phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered in six patients with neovascular age-related macular degeneration, which causes blurred vision or a blind spot in the patient's visual field.

Currently trading at $5.25, the stock has traded between $1.25 and $5.95 in the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3203246/stock-alert-clearside-biomedical-continues-to-trade-higher.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved